Recombinant antibody
US5677425A · kind A · utility
323Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 18, 1994 |
| Grant date | Oct 14, 1997 |
| Priority date | — |
| Expiry date | Aug 18, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/867
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides an altered antibody molecule (AAM) having a hinge region which has a different number of cysteine residues from that found in the hinge region normally associated with the CH1 domain of the antibody molecule and a process for producing the same using recombinant DNA technology.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.